PROSTATE AND PELVIC/OBTURATOR LYMPH NODES; RADICAL PROSTATECTOMY:

HISTOLOGIC TYPE
ACINAR ADENOCARCINOMA

HISTOLOGIC GRADE (PRIMARY PATTERN+SECONDARY PATTERN = GLEASON SCORE):

4+5=9
TERTIARY PATTERN 3

PERCENTAGE OF DIFFERENT GLEASON PATTERNS

Not described
TUMOR LOCATION
APEX
MID
BASE
ANTERIOR
RIGHT
LATERAL
RIGHT
LEFT
POSTERIOR
RIGHT
LEFT
EXTRA-PROSTATIC EXTENSION
PRESENT
FOCAL
SITE OF EXT RA-PROSTATIC EXTENSION
Not determined
SEMINAL VESICAL INVASION
PRESENT
RIGHT
SURGICAL MARGINS
FREE OF INVASIVE CARCINOMA
LYMPHOVASCULAR INVASION
PRESENT
PERINEURAL INVASION
Not described
TUMOR VOLUME/size of the largest nodule
1.6x3x2.8cm=13.44cc
TREATMENT EFFECT ON CARCINOMA
NOT APPLICABLE
LYMPH NODES
NO LYMPH NODES SUBMITTED
NO LYMPH NODES IDENTIFIED
PATHOLOGICAL STAGING
pT3b
pNX
pMX
*COMMENTIS)
Presence of a Ductal component of 25-30%

Iésb-é '5 L

2 E )W 9/4013

CSLEL§V%%JJZJE‘AAD:5(Qﬁﬁfﬁ
can/zq 1/3

UUID:A458AFC5 -774E-4FB2-8191 -735945
TCGA-YL -ABHJ- - EC3E42

HIIIIHIIHIIIIIIIIHIIIIIIIIIIIIIIIIIIIIIIIIIIIlllllIIﬁlclIlaIlcllted

HIIIIIHIIIIIIIIII
mImmInun”:IIIIIII'II'IIIIIIIIIIIIIIIIIIIII‘II‘I‘II"'

 

 

 

 

v4.00
TCGA Pathologic Diagnosis Discrepancy Form

 

 

 

 

 

Instructions; The TCGA Pathologic Diagnosis Discrepancy Form should be completed when the pathologic diagnosis

documented on the initial pathology report for a case submitted for 'l‘CGA is inconsistent with the diagnosis provided on the
Case Quality Control Form completed for the submitted case.

 

 

 

 

 

 

 

 

 

I .
Tissue Source Site (1‘53): .155 Identiﬁer: __ TSS Unique Patient Identiﬁer: _'
Completed By (Interviewer Name on Open'Clinicaj'. , 1. Completed Date: T , ‘
Diagnosis Information I 1
# Data Element Entry Alternatives Workirg Instructions
‘ . ‘ Provide the diagnosis] histologic subtype(s) documented on
Pathologic Diagnosis {A ¥‘ “1" Q RAM) L1"- ‘KPW‘ 1x I the initial pathology report for this case. If the histology for
1 Provided on Initial OLLQJOW this case is mixed, provide all listed subtypes.
Pathology Report w-A'V‘ Bodﬁ\ koanktxA—
. . _ Provide the histologic features selected on the TCGA Case
Histologlc feamtes Of ‘pib‘ \L’ A6“— ‘\‘ kl ‘U - Jx 0“ \ Quality Control Form completed for this case.
2 the sample prowded ___/_____
for 'I‘CGA. as reﬂected -~

 

 

 

ﬁliscrepancy between Pathology Report and Case Quality Control Form

 

 

 

 

 

 

 

 

3 Provide the reason for Provide a reason describing why the diagnosis on the initial
. s . ~ pathology report for this case is not consistent with the

the discrepancy Q I J V J 0‘ U) Q LN ‘\ K. diagnosis selected on the 'I‘CGA Case Quality Control Form.
between the pathology
report and the TCGA \
Case Quality Control <3 £er ‘\ ° 3' “ "L\V «L.
Form. ,

b\&kL\ Ks w Q «\th

’\ ‘.

kQ ’Lv- Q\ no) LRSvL\

Name of TSS Reviewing _ Em'l‘ide the name of the pathologist who reviewed this case
4 Pathologist or ”r can.

Biorepository Director

 

 

l acknowledge that the above Information provided by my institution is true and correct and has been quality controlled.

TSS Reviewing Pathologist or Bioreposltdry Director Date

I acknowledge that the above information provided by my institution is true and correct and has been quality controlled. The Attending Pathologist or the
Department Chairman has been informed or is aware of the above discrepancy in diagnoses.

 

’ Principal Investigator Signature Date'

